Project Details
Projekt Print View

Depicting the function of Regnase-3, a new posttranscriptional regulator, in immune responses

Subject Area Immunology
Cell Biology
Term from 2015 to 2019
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 286205495
 
Final Report Year 2019

Final Report Abstract

The DFG grant was funded to identify the role of Regnase-3 for immune responses and its mode of action. Therefore, we analyzed Regnase-3-deficient mice, which develop hypertrophic lymph nodes. To do so, we used various mice with immune cell-specific deletions of Regnase-3 and demonstrated that Regnase-3 acts specifically within myeloid cells. We showed with immunohistochemistry, FACS analysis and Sequencing approaches that Regnase-3 deficiency systemically increased IFN signaling. This then resulted in an increase of immature B and innate immune cells in lymph nodes and suppressed follicle and germinal center formation. We generated our own Regnase-3-specific antibody, which allowed us to perform expression and localization analysis using primary immune cells. This revealed that Regnase-3 and Regnase-1 actually do share protein degradation pathways. Nevertheless, unlike Regnase-1, Regnase-3 expression is high specifically in macrophages and is transcriptionally controlled by IFN signaling. Although we had extreme difficulties to identify the direct targets in macrophages, which still remain unknown, we demonstrated that Regnase-3 can bind, degrade, and regulate mRNAs, such as Zc3h12a (Regnase-1), in vitro. Finally, we unmasked Regnase-3, like Regnase- 1, is an RNase essential for immune homeostasis but has diverged as key regulator in the IFN pathway in macrophages.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung